Skip to main content
. 2012 May 14;2012:176789. doi: 10.5402/2012/176789

Table 1.

Patient demography at screening.

Docetaxel alone (n = 9) Gefitinib + docetaxel (n = 9)
Age (range; years) 53.1 (35–69) 56.3 (37–67)
Weight/height 70.4 kg/164 cm 70.4 kg/164 cm
Performance status
 WHO grade 0 5 4
 WHO grade 1 3 4
 WHO grade 2 1 1
Previous therapy for metastatic disease
 None 1 5
 Endocrine therapy 6 3
 Antracycline 1 1